Hypertrophic cardiomyopathy and sudden death: New perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator

European Heart Journal

Volumn 21, Issue 24, 2000, Pages 1979-1983

  Maron, B J ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CORONARY ARTERY DISEASE; CORONARY RISK; DEFIBRILLATOR; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RISK ASSESSMENT;

EID: 0034538027     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2238     Document Type: Review

References (26)

1. Hypertrophic cardiomyopathy
2. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
3. The management of hypertrophic cardiomyopathy
4. Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy
5. Asymmetrical hypertrophy of the heart in young patients
6. Hypertrophic cardiomyopathy: An important cause of sudden death
7. Sudden death in hypertrophic cardiomyopathy: Profile of 78 patients
8. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral based patient population
9. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history
10. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia
11. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy
12. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
13. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
14. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
15. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
16. Hypertrophic cardiomyopathy and sudden death
17. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
18. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
19. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
20. Internal ventricular defibrillation
21. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
22. Extreme left ventricular hypertrophy
23. Clinical consequences of hypertrophic cardiomyopathy in an unselected regional United States cohort
24. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy
25. Survival after cardiac arrest in patients with hypertrophic cardiomyopathy
26. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients